StemEdit Gene Edited iPSCs

Brand: StemEdit by Stemgent® (REPROCELL®)

High-quality HLA knockout iPSC lines were developed using our state-of-the-art genome editing technology, utilizing an AI-enhanced nuclease system. This editing system is also well-suited for clinical gene-editing projects.

NOTE: These iPSC cell lines are developed and supplied for Research Use Only (RUO). They are not intended for clinical or therapeutic applications. However, this clone has a clinical-grade counterpart available that is suitable for clinical gene editing and downstream clinical development. Contact Us for more information.

See also:

StemEdit OC-1 Protein — Our license-free AI-designed protein for robust gene editing.
StemEdit Clinical Gene Editing Service — Our license-free editing services.
Clinical Stem Cell Services — Clinical-grade iPSC solutions.
StemRNA™ Induced Pluripotent Stem Cells (iPSCs) — Research-grade iPSC collection.

NEW OFFER: the clinical parental control iPSC line—used to develop our StemEdit hypoimmune iPSC lines—is now available in an affordable bundle with these gene-edited clones.

Interested? Reach out directly at info-us@reprocellusa.com for details.

Products:

StemEdit hiPSC CIITA KO RPC-LLF-34-F3

Brand: StemEdit

RCRP051

Human iPSCs with a knockout of both copies of the CIITA gene.